Jia-Horng Kao Selected Research

Jia-Horng Kao Research Topics

Disease

150	Infections 08/2022 - 01/2002
104	Chronic Hepatitis B 03/2022 - 01/2002
91	Fibrosis (Cirrhosis) 03/2022 - 09/2002
77	Chronic Hepatitis C 01/2022 - 10/2002
63	Hepatitis B 05/2022 - 01/2002
62	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 09/2002
33	Liver Diseases (Liver Disease) 01/2022 - 09/2002
31	Hepatitis 06/2021 - 01/2003
24	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 07/2005
20	Disease Progression 01/2022 - 09/2006
20	Hepatitis C 06/2020 - 11/2002
19	Neoplasms (Cancer) 08/2022 - 04/2002
18	Virus Diseases (Viral Diseases) 02/2022 - 01/2007
14	Chronic Hepatitis (Chronic Active Hepatitis) 11/2012 - 09/2002
9	Insulin Resistance 10/2014 - 08/2005
8	Coinfection 05/2022 - 01/2002
7	Fatty Liver 04/2021 - 01/2005
6	Viremia 12/2020 - 01/2003
5	Non-alcoholic Fatty Liver Disease 03/2021 - 08/2009
5	Inflammation (Inflammations) 06/2014 - 01/2005
4	Chronic Renal Insufficiency 01/2022 - 06/2011
4	Persistent Infection 07/2010 - 01/2003
3	Carcinogenesis 01/2022 - 12/2018
3	Hyperbilirubinemia 03/2018 - 04/2007
3	Obesity 01/2018 - 05/2010
3	Body Weight (Weight, Body) 10/2015 - 11/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2010 - 08/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010 - 01/2005
2	Liver Neoplasms (Liver Cancer) 08/2022 - 01/2022
2	Diabetes Mellitus 01/2022 - 05/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 08/2021 - 02/2011
2	Hemorrhage 07/2020 - 12/2016
2	HIV Infections (HIV Infection) 07/2020 - 04/2007
2	Metabolic Diseases (Metabolic Disease) 01/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

84	Antiviral Agents (Antivirals)IBA 05/2022 - 01/2003
74	InterferonsIBA 10/2021 - 11/2002
72	Hepatitis B e AntigensIBA 01/2022 - 01/2002
60	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2021 - 10/2002
57	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2002
48	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 11/2002
34	Alanine Transaminase (SGPT)IBA 08/2021 - 01/2003
22	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2006
17	SofosbuvirIBA 02/2022 - 01/2016
17	entecavir FDA Link 01/2022 - 01/2006
16	Lamivudine (Epivir)FDA Link 02/2015 - 02/2002
13	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2003
12	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 01/2006
11	AntigensIBA 01/2022 - 01/2002
11	Pharmaceutical PreparationsIBA 04/2021 - 08/2008
11	daclatasvirIBA 01/2021 - 11/2014
10	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020 - 11/2006
8	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2022 - 06/2003
8	asunaprevirIBA 01/2021 - 11/2014
8	Interferon-alpha (Interferon Alfa)IBA 07/2016 - 12/2002
7	AdiponectinIBA 04/2015 - 08/2005
6	sofosbuvir drug combination ledipasvirIBA 08/2022 - 07/2016
6	glecaprevir and pibrentasvirIBA 01/2021 - 10/2018
5	CytokinesIBA 05/2022 - 12/2011
5	velpatasvirIBA 02/2022 - 12/2018
5	Proteins (Proteins, Gene)FDA Link 02/2022 - 09/2011
5	nasIBA 01/2022 - 01/2014
5	NucleotidesIBA 06/2021 - 10/2002
5	CholesterolIBA 09/2020 - 07/2007
5	VaccinesIBA 01/2020 - 09/2011
5	LipidsIBA 01/2020 - 06/2008
5	ledipasvirIBA 12/2018 - 06/2016
5	Surface Antigens (Surface Antigen)IBA 03/2018 - 06/2012
5	Transaminases (Aminotransferases)IBA 08/2017 - 11/2006
5	Codon (Codons)IBA 07/2014 - 01/2002
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 07/2016
4	Triglycerides (Triacylglycerol)IBA 01/2020 - 06/2008
4	Ritonavir (Norvir)FDA Link 12/2018 - 10/2016
4	Telbivudine FDA Link 01/2017 - 01/2014
4	peginterferon alfa-2b (Pegintron)FDA Link 10/2014 - 01/2006
3	Tenofovir (Viread)FDA Link 01/2022 - 01/2010
3	BilirubinIBA 01/2022 - 03/2018
3	Sorafenib (BAY 43-9006)FDA Link 11/2017 - 06/2015
3	Viral DNAIBA 08/2017 - 11/2006
3	Genetic Markers (Genetic Marker)IBA 06/2017 - 05/2015
3	NucleosidesIBA 06/2016 - 01/2013
3	AdipokinesIBA 04/2015 - 02/2008
3	adefovir dipivoxil (Hepsera)FDA Link 02/2015 - 01/2006
3	Complement System Proteins (Complement)IBA 09/2014 - 01/2013
3	Amino Acids FDA Link 01/2011 - 09/2002
2	acarboxyprothrombin (PIVKA)IBA 08/2022 - 03/2022
2	ChemokinesIBA 05/2022 - 08/2014
2	Iodized OilIBA 02/2022 - 10/2021
2	AlbuminsIBA 10/2021 - 12/2020
2	Circular DNAIBA 06/2020 - 08/2014
2	TransferasesIBA 01/2020 - 09/2009

Therapy/Procedure

134	Therapeutics 05/2022 - 04/2002
11	Liver Transplantation 03/2021 - 01/2008
9	Renal Dialysis (Hemodialysis) 03/2019 - 01/2005
6	Aftercare (After-Treatment) 01/2022 - 07/2005
6	Duration of Therapy 06/2020 - 05/2005
5	Drug Therapy (Chemotherapy) 01/2020 - 01/2008
4	Highly Active Antiretroviral Therapy (HAART) 02/2012 - 02/2007
3	Kidney Transplantation 05/2011 - 07/2010
2	Radiofrequency Ablation 02/2022 - 10/2021
2	Organ Transplantation 07/2020 - 01/2019